Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Breast Cancer. 2003 Jun;4(2):142-5.

A Phase I/II Trial of trastuzumab and gefitinib in patients with Metastatic Breast Cancer that overexpresses HER2/neu (ErbB-2).

Author information

1
Comprehensive Breast Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. emouldesl@moffitt.usf.edu
PMID:
12864943
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center